重编程工程化自体 T 细胞以克服 Merkel 细胞癌患者的耐药性
Reprogramming engineered autologous T cells to overcome resistance in patients with Merkel cell carcinoma.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Cellular behavior analysis from live-cell imaging of TCR T cell-cancer cell interactions.
Cellular behavior analysis from live-cell imaging of TCR T cell-cancer cell interactions.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
嵌合抗原受体(CAR)T细胞和T细胞受体(TCR)T细胞等T细胞疗法正逐渐成为一类抗癌治疗方法。然而,若要扩展至新适应证并用于末线治疗之前,需要通过工程设计调控细胞群体的动态行为。
本研究开发了基于活细胞成像分析T细胞细胞行为的工具,这种实验方式常见且成本较低,适用于评估工程化T细胞。研究者首先开发了基于人在回路深度学习的先进分割和追踪流程Caliban。随后建立Occident流程,用于整理细胞群体、形态、运动和相互作用的表型目录,研究对象为修饰T细胞与抗原呈递肿瘤细胞的共培养体系。研究使用Caliban和Occident,探究在TCR-T细胞中引入有益的RASA2或CUL5基因敲除后,T细胞与癌细胞之间的相互作用差异。研究进一步使用时空模型量化T细胞在接触癌细胞后的募集和增殖。与安全位点敲除对照相比,RASA2敲除T细胞与癌细胞接触时间更长,导致T细胞活化增强、杀伤效力提高;而CUL5敲除T细胞增殖率更高,因而产生更多可用于搜寻靶细胞的T细胞。
总之,Caliban实现的分割和追踪以及Occident实现的表型量化,支持细胞行为分析,有助于优化T细胞疗法以改善癌症治疗。
T cell therapies, such as chimeric antigen receptor (CAR) T cells and T cell receptor (TCR) T cells, are a growing class of anti-cancer treatments.
However, expansion to novel indications and beyond last-line treatment requires engineering cells' dynamic population behaviors.
Here we develop the tools for cellular behavior analysis of T cells from live-cell imaging, a common and inexpensive experimental setup used to evaluate engineered T cells.
We first develop a state-of-the-art segmentation and tracking pipeline, Caliban , based on human-in-the-loop deep learning.
We then build the Occident pipeline to collect a catalog of phenotypes that characterize cell populations, morphology, movement, and interactions in co-cultures of modified T cells and antigen-presenting tumor cells.
We use Caliban and Occident to interrogate how interactions between T cells and cancer cells differ when beneficial knock-outs of RASA2 and CUL5 are introduced into TCR T cells.
We apply spatiotemporal models to quantify T cell recruitment and proliferation after interactions with cancer cells.
We discover that, compared to a safe harbor knockout control, RASA2 knockout T cells have longer interaction times with cancer cells leading to greater T cell activation and killing efficacy, while CUL5 knockout T cells have increased proliferation rates leading to greater numbers of T cells for hunting. Together, segmentation and tracking from Caliban and phenotype quantification from Occident enable cellular behavior analysis to better engineer T cell therapies for improved cancer treatment.
MEMBER ACCOUNT
登录成功会直接打开下一页。